Over this same period, the FDA has issued warnings about compounded semaglutide
These results indicate that the higher doses of dulaglutide may be underutilized and that the initial non-maintenance dose of semaglutide may be prescribed for a longer time than recommended, thus suggesting a clinical inertia in the management of T2DM, which results in patients glycemia not being under control
Moreover, hospital pharmacies benefit from robust inventory management systems, allowing for a consistent supply of temperature-sensitive formulations
1 It could be inferred that tirzepatide might offer an advantage for long-term maintenance simply because individuals may be maintaining a lower overall body weight if treatment is continued consistently
Clinical Note: These outcomes are based on trials involving FDA-approved semaglutide products
Kaiser coverage varies by plan, and you may need prior authorization, step therapy, or quantity limits for Mounjaro